Company Filing History:

5 out of 46

Pierre Fabre S.a.

patents

3 out of 266

Pierre Fabre Medicament

Years Active: 1981-1994

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5362474 - Method for detecting and locating inflammatory or tumor foci in a (1994-11-08),

2. 4937327 - Derivative of D.25, process for its preparation, its use as an (1990-06-26),

3. 4933440 - Immunomodulators obtained semisynthetically from a bacterial (1990-06-12),

4. 4734403 - Membrane polysaccharides which are useful as immunostimulants (1988-03-29),

5. 4501693 - Method of preparing immunostimulant proteoglycans which induce (1985-02-26),

6. 4460575 - Vaccinal complex containing a specific antigen and vaccine containing it (1984-07-17),

7. 4397838 - Preparations of purified bacterial membranal proteoglycans (1983-08-09),

8. 4389396 - Immunostimulating preparations based on ribosomal RNA's and a process (1983-06-21),

9. 4297272 - Process for the preparation of purified bacterial membranal proteoglycans (1981-10-27),

Title: Innovations of Anne-Marie Pinel

Introduction

Anne-Marie Pinel is a notable inventor based in Castres, France. She has made significant contributions to the field of biomedical research, particularly in the development of innovative methods for detecting and treating inflammatory conditions and tumors. With a total of nine patents to her name, her work has the potential to impact medical diagnostics and therapeutics.

Latest Patents

Among her latest patents is a method for detecting and locating inflammatory or tumor foci. This invention involves an aerosol composition that contains a carrier agent capable of recognizing and binding to inflammatory and tumor foci, mobilizing macrophages in their immediate environment. The carrier agent consists of a polysaccharide compound extracted from the membrane proteoglycans of the bacterium Klebsiella pneumoniae. Another significant patent is related to a polysaccharide derivative, which is a modified form of D.25, where galactofuranose residues have been converted to arabinose. This derivative is intended for use as an immunostimulant and in pharmaceutical compositions.

Career Highlights

Anne-Marie Pinel has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre S.A. and Pierre Fabre Medicament. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.

Collaborations

Throughout her career, Anne-Marie has collaborated with esteemed colleagues such as Gerard Normier and Lucien D D'Hinterland. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Anne-Marie Pinel's contributions to the field of biomedical innovation are noteworthy. Her patents reflect her commitment to advancing medical technology and improving patient outcomes. Her work continues to inspire future innovations in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.